Canada Relies On Emergent Data To Vouch For AstraZeneca Vaccine Donated By U.S.

By Kelly Lienhard / April 26, 2021 at 12:34 PM
Canada’s drug regulation authority is relying on information provided by Emergent BioSolutions’ troubled manufacturing facility in Baltimore, which recently halted its production of COVID-19 vaccines after an FDA inspection found deficient manufacturing practices dating back to February, to vouch for millions of doses of AstraZeneca’s COVID-19 vaccine donated by the United States last month prior to the inspection findings. FDA conducted an inspection at the partially government-funded facility after Johnson & Johnson took over manufacturing in early April 2021 due...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.